Human T-cell leukemia virus and simian T-cell leukemia virus (STLV) form the primate T-cell lymphotropic viruses group. Human T-cell leukemia virus type 1 and type 2 (HTLV-1 and HTLV-2) encode the Tax viral transactivator (Tax1 and Tax2, respectively). Tax1 possesses an oncogenic potential and is responsible for cell transformation both in vivo and in vitro. We and others have recently discovered the existence of human Tcell lymphotropic virus type 3. However, there is currently no evidence for the presence of a Tax protein in HTLV-3-infected individuals. We show that the serum of an HTLV-3 asymptomatic carrier and the sera of two STLV-3-infected monkeys contain specific anti-Tax3 antibodies. We also show that tax3 mRNA is present in the PBMCs obtained from an STLV-3-infected monkey, demonstrating that Tax3 is expressed in vivo. We further demonstrate that Tax3 intracellular localization is very similar to that of Tax1 and that Tax3 binds to both CBP and p300 coactivators. Using purified Tax3, we show that the protein increases transcription from a 4TxRE G-free cassette plasmid in an in vitro transcription assay. In all cell types tested, including transiently transfected lymphocytes, Tax3 activates its own promoter STLV-3 long terminal repeat (LTR), which contains only two Tax Responsive Elements (TREs), and activates also HTLV-1 and HTLV-2 LTRs. In addition, Tax3 also activates the NF-jB pathway. We also show that Tax3 possesses a PDZ-binding sequence at its C-terminal end. Our results demonstrate that Tax3 is a transactivator, and that its properties are more similar to that of Tax1, rather than of Tax2. This suggests the possible occurrence of lymphoproliferative disorders among HTLV-3-infected populations.
Introduction
Human T-cell leukemia virus type 1 and type 2 (HTLV-1 and HTLV-2) are related human retroviruses that infect T lymphocytes. While HTLV-1 infection can cause the aggressive adult T-cell leukemia/lymphoma (ATLL), HTLV-2 has not been demonstrated to be the agent of a hematological malignant disease (Mahieux and Gessain, 2003) . Together with their related simian counterparts, HTLVs form the primate T-cell lymphotropic viruses (PTLV) lineages (Guo et al., 1984; Hunsmann et al., 1984) . So far, four types of PTLVs have been discovered in primates (Slattery et al., 1999; Van Brussel et al., 1999; Calattini et al., 2005; Wolfe et al., 2005) . While three of them, that is, PTLV-1, PTLV-2 and PTLV-3, comprise human and simian viruses (HTLV-1, HTLV-2, HTLV-3 and STLV-1, STLV-2, STLV-3 respectively) (Calattini et al., 2005) , the fourth type (HTLV-4) consists only of one human strain (Wolfe et al., 2005) . Isolated for the first time shortly after HTLV-1 (Miyoshi et al., 1982) , STLV-1 is highly prevalent in a large variety of old world monkey species (Slattery et al., 1999) , and cases of ATLL-like diseases, with clonal integration of the STLV-1 provirus in the tumor cells described in several simian species (Blakeslee et al., 1987) . Based on env, pol and/or long terminal repeat (LTR) sequence comparisons, phylogenetic analyses have provided supporting evidence that multiple discrete episodes of interspecies transmission have occurred between primates and humans in the distant and recent past (Slattery et al., 1999) .
By contrast, STLV-2 strains have only been identified in few bonobo chimpanzees (Pan paniscus) (Giri et al., 1994; Liu et al., 1994) .
STLV-3, (formerly named PTLV-L) was isolated shortly before STLV-2 . Although much more prevalent than STLV-2 in Africa, STLV-3 has not been linked to any pathology so far Van Brussel et al., 1996 Van Dooren et al., 2001 Meertens et al., 2002 Takemura et al., 2002; Courgnaud et al., 2004) . Sequence comparisons of STLV-3 fulllength proviruses indicated that these strains are highly divergent from HTLV-1 (60% nucleotide similarity), HTLV-2 (62%) or STLV-2 (62%) prototype sequences (Van Brussel et al., 1996; Meertens et al., 2002) . HTLV-3, the human counterpart of STLV-3 was discovered very recently (Calattini et al., 2005; Wolfe et al., 2005) . In all phylogenetic analyses, STLV-3 and HTLV-3 cluster in a highly supported clade, indicating an evolutionary lineage independent from PTLV-1 and PTLV-2 (Meertens et al., 2002; Calattini et al., 2005; Wolfe et al., 2005) .
Both HTLV-1 and HTLV-2 pX regions encode Tax proteins (Ross et al., 1996; Mahieux and Gessain, 2003) . Tax1 possesses an oncogenic potential and is responsible for the cell transformation both in vivo and in vitro (Jeang et al., 2004) . Interestingly, even if it possesses an ORF corresponding to the tax gene, the STLV-3 pX region organization is different from that of PTLV-1 and PTLV-2, with the absence of ORFs that would be equivalent to p12, p13 and p30 (Van Brussel et al., 1996; Meertens et al., 2002) . At the amino-acid level, the available putative human HTLV-3 Tax protein sequence (Tax3 H ) possesses only 75 and 79% similarity with HTLV-1 and HTLV-2 Tax proteins (Tax1 and Tax2) (Wolfe et al., 2005) , but 97% identity with the putative simian STLV-3 602 Tax protein. Given the recent discovery of HTLV-3 (Calattini et al., 2005; Wolfe et al., 2005) , the large and increasing number of simian species infected with STLV-3 and the known transactivating ability of Tax proteins (Jeang et al., 2004) , the Tax3 molecular properties needed to be investigated. The aims of the present study were therefore to assess the Tax3 protein for (a) expression in vivo, (b) transactivation ability through the NF-kB and Cyclic AMP Response Element Binding (CREB) pathways and further transformation of human and simian cells in vivo, (c) mediation capacity for transcription of the autologous LTR in spite of lacking the distal TRE sequence (Van Brussel et al., 1997; Meertens et al., 2002 Van Dooren et al., 2004) .
We demonstrate here that Tax3 is similar to Tax1: its intracellular localization, its ability to bind the CREBbinding protein (CBP) and p300 co-activators and the presence of a PDZ domain at the C-terminus end of the protein sequence are reminiscent of Tax1. Given that the PDZ domain has been shown to be critical for the protein's ability to transform cells in vitro, our results suggest that HTLV-3 might be as pathogenic as HTLV-1 in vivo.
Results
In order to investigate whether tax3 gene is transcribed ex vivo, a tax3-specific reverse transcriptase PCR (RT-PCR) was performed with mRNA extracted from a short term-culture of PBMCs isolated from an STLV-3 infected monkey. The presence of a band at the expected size demonstrated that tax3 is transcribed ( Figure 1a , lane 2). The tax3 cDNA was then cloned into different vectors. To determine whether Tax3 is expressed in vivo, Tax3 histidine-tagged protein was purified from Escherichia coli by nickel-affinity chromatography (QIAGEN) as previously described . Using this purification technique, the protein is greater than 95% pure when analysed by SDS-PAGE followed by a Coomassie blue stain (Figure 1b) (Duvall et al., 1995) . Tax3 purified protein was then used as an antigen to detect anti-Tax3 antibodies in serial dilutions of the serum obtained from the previously described HTLV-3-infected individual (Pyl43) (Calattini et al., 2005) , as well as in the sera from several African monkeys. Such a technique has previously been used for detecting anti-Tax1-specific antibodies among HTLV-1-infected patients (Coates et al., 1990; Chen et al., 1997; Hisada et al., 1998) . Using a sensitive PCR technique with HTLV-1-and HTLV-2-specific PCR primers, we previously demonstrated that neither the individual infected with HTLV-3 nor the monkeys infected with STLV-3 were also co-infected with HTLV-1/STLV-1 or HTLV-2/STLV-2 Calattini et al., 2005) . This rules out the possibility that any Tax reactivity could be because of antibodies directed against another known PTLV Tax protein. While we did not detect any signal with the control HTLV-3 free human serum ( Figure 1c , lanes 1-5), a band that corresponds to Tax3 was detected in the 1:250 and 1:500 serum dilutions of Pyl43 (Figure 1c , lanes 6-7), demonstrating for the first time that Tax3 is expressed in the HTLV-3-infected human individual. As a control for Tax protein loading, the membrane was reprobed with anti-histidine antibody (Figure 1c , lower panel). To determine whether Tax3 antibodies are also present in STLV-3-infected animals, a series of monkey sera was tested. To find out which animals were infected with STLV-3, high molecular weight DNA was extracted from uncultured PBMCs and subjected to STLV-3-specific PCR as previously described ) (see Figure 1d , bottom of the upper panel for the PCR results). In this series, five animals (F5, F7, F8, F9, 604) out of nine were found to be STLV-3 PCR positive (Figure 1d ). Anti-Tax3-specific antibodies were then detected in two out of the five STLV-3-infected animals. Interestingly, this percentage is similar to what was previously observed in HTLV-1 asymptomatic carriers (Chen et al., 1997) . As expected, none of the STLV-3 PCR-negative animals had antibodies against Tax3 in their sera/plasma. As a control for Tax protein loading, the membrane was reprobed with anti-his antibody (Figure 1d , lower panel).
Multiple Tax1, Tax2 and Tax3 amino-acid sequence alignments were then performed with the ClustalW algorithm implemented in MacVector 6.5 (Oxford Molecular). Representative PTLV-1, PTLV-2, STLV-3 (Tax3 S ) as well as the two published partial HTLV-3 Tax (Tax3 H ) amino-acid sequences were aligned using a PAM 250 matrix and the Tax domains were then analysed. As shown in Figure 2 , most of the previously reported Tax domains were conserved in human and simian Tax3 sequences. Of interest, the Tax3 putative KID-like-binding domain sequence (aa 81-95) (Harrod et al., 1998) is very similar to that of Tax1 and of Tax2, with one amino-acid change as compared to Tax2a and two as compared to Tax1 and Tax2b. Interestingly, the two amino acids corresponding to the M22 domain (aa 130-131) (Smith and Greene, 1990) are modified in the Tax3 vs Tax1 protein. The stretch of amino acid that is analogous to the previously reported Nuclear Export Signal of Tax1 (aa 188-202) (Alefantis et al., 2003) also contains several changes, but none of them corresponding to an essential leucine or isoleucine residue. Some changes are also present in the putative Tax3 S CR2-binding sequence (aa 312-319) . This domain has been shown to be essential for CBP/p300 binding (Scoggin et al., 2001) . Finally, and as in Tax1 but not in Tax2 (Rousset et al., 1998; Hirata et al., 2004) , a putative class I PDZ-binding domain (Nourry et al., 2003) is present in all the simian Tax3 sequences that are available for analysis.
We then undertook an extensive molecular analysis of Tax3 properties: since Tax localization in the nucleus is critical for its ability to transactivate the viral promoter , we initially took advantage of the previously described GFP-Tax-based system to determine the intracellular localization of the protein (Meertens et al., 2004a) . In transient transfection assays, the GFP-Tax3 S fusion protein has a strong nuclear localization that is similar to that of Tax1 and different from that of Tax2, suggesting that it contains a functional NLS domain (Figure 3a ). Western blot analysis using the GFP antibody was performed and demonstrated that all proteins were expressed to similar levels ( Figure 3b ). As a control for protein loading, the membrane was stripped and reprobed with an anti b-tubulin antibody (Figure 3b, lower panel) .
Given that binding to the co-activators is critical for Tax1 and Tax2-mediated transactivation (Kwok et al., 1996; Harrod et al., 1998; Kashanchi et al., 1998; Meertens et al., 2004b) , we also undertook a series of experiments aiming at determining whether Tax3 could bind the CBP and p300 coactivators. Using the GFP, GFP-Tax1, GFP-Tax2 and GFP-Tax3 S proteins Characterization of the HTLV/STLV-3 Tax protein SA Chevalier et al expressed from 293T-transfected cells, we performed a series of co-immunoprecipitations as previously described (Meertens et al., 2004b) . Although this technique is qualitative rather than quantitative, Tax3 binding appears to be lower than Tax1 and Tax2 on the interaction with purified full-length p300 ( Figure 4a , lane 4 vs lanes 2 and 3). On the contrary, Tax1 and Tax3 seem to bind equivalently to purified full-length CBP ( Figure 4c , lanes 2 and 3). As previously reported (Meertens et al., 2004b) , GFP-Tax2 seems to bind less efficiently to CBP than GFP-Tax1 and GFP-Tax3. As a control, the GFP and GFP-Tax protein input were assessed (Figure 4b, d) . To compare the interactions of Tax1 and Tax3 S with p300 and CBP, we performed another series of experiments using purified Tax1 and Tax3 together with several GST-CBP and GST-p300 constructs that contain either the CH/1, and/or the KIX or the C/H2 domains. Both C/H1 and KIX domains have been shown to bind Tax1 (Harrod et al., 1998; Lemasson and Nyborg, 2001 ). Interestingly, Tax3 To determine whether Tax3 is a viral transactivator, we then investigated whether the purified Tax3 protein was able to activate transcription from an HTLVderived promoter. To this end, the HTLV-1 LTR G-free Characterization of the HTLV/STLV-3 Tax protein SA Chevalier et al cassette was used as a template (Figure 5a) (Kashanchi et al., 1998) . To perform a titration, increasing amounts of purified Tax1 and Tax2 proteins were also used. As previously reported, in the absence of Tax, a basal transcription is present (Figure 5b, lane 1) . The addition of either Tax1, Tax2 or Tax3 S to the in vitro transcription reaction led to significant increase in 21-bp-dependent transcription (Figure 5b , compare lanes 2 and 4, 6 and 8, 10 and 12), demonstrating that the transcription was dependent on Tax. Interestingly, when the in vitro transcription reaction was performed in the presence of 500 ng of Tax, the amount of RNA that is being transcribed is slightly lower (Figure 5b , compare, e.g., lanes 8 and 9, 12 and 13). This is consistent with a squelching of the transcription factors by an excess of free Tax protein.
Using a series of transient transfection assays, we then determined whether Tax3 can mediate the transactivation of the autologous LTR (STLV-3 LTR) in lymphocytes, the natural target of HTLVs infection in vivo. A 445 bp region encompassing the U3 and part of the R sequences was therefore amplified from STLV-3 and cloned as previously described (Casoli et al., 2004) . Interestingly, the STLV-3 LTR is shorter than that of HTLV-1 and HTLV-2, with only two 21-bp repeats (TRE) in the U3 region. This is because of a deletion of the TATA-distal 21-bp repeat in the U3 region (Van Brussel et al., 1997; Meertens et al., 2002) (Figure 6a ). In HTLV-1 LTR, these three TREs are functionally nonequivalent in the absence of Tax1 (i.e. for basal transcription), the middle TRE being the most critical (Barnhart et al., 1997) . In the presence of Tax1, the presence of only two TREs is sufficient for a high level of Tax1-mediated LTR activation in transfected cells (Brady et al., 1987) . Because co-infection by STLV-1 and STLV-3 has been reported to occur naturally (Courgnaud et al., 2004) , we also investigated whether Tax3 S could transactivate the heterologous human viral promoters (LTR1 and LTR2, respectively). The pSG5M-Tax3 S plasmid was transfected together with HTLV-1, HTLV-2 or STLV-3 LTR constructs in different cell lines (see Figure 6b -e, for the CEM results and data not shown for other cell lines). Interestingly, in CEM cells, Tax3 S transactivates the STLV-3 promoter (Figure 6b ) and also HTLV-1 and HTLV-2 promoters (Figure 6c and d) . As seen on Figure 6e , Tax3 S also activates the NF-kB pathway in CEM cells. Similar results were also obtained in Jurkat, Hela and HEK cells (data not shown). As a control, Tax3 expression was monitored in the transiently transfected CEM cells (Figure 6f ). After RT-PCR, a Tax-specific band was present in the Tax3-transfected CEM extracts. This band was absent in non-transfected cells (Figure 6f , left panel lane 1), or when the RT was not added to the PCR mix (Figure 6f, right panel lane 4) .
It is interesting that, even if the amino acids #130 and 131 of Tax3 S (A and M, respectively) are different from that of Tax1 (T 130 -L 131 ), yet the protein still activates the NF-kB pathway (Figure 6e ). Because the Tax1 M22 mutant (A 130 -S 131 ) that is impaired for NF-kB activation shares an alanine at position 130 with Tax3, this suggests that in Tax1 M22 , M 131 is critical for preventing the Tax-dependant NF-kB activation. To rule out if this is the case, we mutated M 131 of Tax3 to S 131 . The construct was then compared to Tax3wt as far as its ability to activate the CREB and NF-kB pathways (Figure 7a and b) . Tax3 A130-S131 retains its ability to activate the CREB pathway (Figure 7a ), while it is largely impaired for NF-kB activation (Figure 7b ). This suggests that the presence of an alanine at position 130 in the Tax3 sequence has no effect on the NF-kB activation, while the methionine at position 131 is equivalent to the leucine that is present in Tax1.
As stated above, sequence analysis of the C-terminus end of Tax3 S revealed that the protein, as Tax1 but not Tax2, may contain a class I PDZ-binding motif (Figure 8a ). We therefore determined whether Tax3 S could bind a protein that contains such a sequence. To this end, we used the clone 15-expressing plasmid (Rousset et al., 1998) . Clone 15 binds Tax1 (Rousset et al., 1998) and has previously been shown to be highly homologous to PSD-95, a cellular protein that contains several PDZ domains. 293T cells were transfected with clone 15 and either GFP or GFP-Tax constructs. As expected, the Tax1 protein was shown to bind strongly to clone15. As a negative control, Tax2 does not bind the PDZ-containing protein clone 15. As anticipated from the sequence comparison, Tax3 S binds clone 15, demonstrating that this protein contains a PDZ-binding motif. GFP, GFP-Tax1, GFP-Tax2 and GFP-Tax3 S and clone 15 input levels were assessed and revealed that identical amounts of proteins have been used for the immunoprecipitations.
Discussion
While PTLV-1 and PTLV-2 include human and simian viruses (HTLV-1, HTLV-2 and STLV-1, STLV-2, respectively), the third type (PTLV-3) consisted until recently of simian STLV-3 strains. STLV-3 provirus , and a recent report convincingly proved that a number of agile mangabeys that live in Cameroon are naturally co-infected with STLV-1 and STLV-3 (Courgnaud et al., 2004) . The HTLV-1-mediated cellular transformation is a multistep process that is made possible by the pleiotropic effects of the viral Tax1 protein (Jeang et al., 2004) . Several lines of evidence have demonstrated a pivotal role for the HTLV-1 Tax protein in the immortalization or transformation of the HTLV-1-infected cells. As an example, the transduction of the tax1 gene into primary human T lymphocytes using a defective simian herpes virus is sufficient to immortalize them (Grassmann et al., 1989) . Likewise, the expression of Tax1 or the co-transfection of Tax1 and Ras in 
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SA Chevalier et al rodent fibroblasts or T lymphocytes is sufficient to transform them (Pozzatti et al., 1990) . Wild-type Tax1 can also convert IL-2-dependent murine CTLL cells to an IL-2-independent stage (Iwanaga et al., 1999) . Finally, Tax1 transgenic animals expressing Tax under the control of the granzyme B promoter develop peripheral lymphomas consisting of CD8 þ and natural killer cells (Grossman et al., 1995) . Tax1 interacts with transcription factors and activates the cyclic-AMP response element and activating transcription factor (ATF) binding (CREB/ATF) pathway, the NF-kB pathway and the serum response factor (SRF) pathway. Tax activation of CREB/ATF is needed for an efficient viral gene expression, while the permanent activation of NF-kB has been suggested to be critical for evading apoptosis in HTLV-1-infected cells (Watanabe et al., 2005) . Consistent with this, a large body of evidence indicates that Tax activates a number of cellular genes involved in the regulation of the cellular proliferation and interferes with the cell cycle control machinery. Nevertheless, the precise mechanism by which Tax initiates the malignant process is still a matter of investigation, but likely involves several points of transcriptional and/or post-transcriptional deregulation in the infected T lymphocytes (Jeang et al., 2004) . More recently, the presence of a PDZ-binding domain in the C-terminus end of Tax1 has also been suggested to be involved in the ability of the viral protein to elicit cell transformation (Endo et al., 2002) .
The pX region of PTLV-3 contains an ORF that is equivalent to the tax gene and the alignment of simian and available human Tax3 reveals that these sequences are highly related (97-99% identity). Our RT-PCR results as well as the presence of Tax3-specific antibodies in the sera of both an HTLV-3-infected individual and of several STLV-3-infected animals demonstrate for the first time that Tax3 is expressed in vivo. This prompted us to examine the different functions of Tax3 S . Interestingly, our results demonstrate that Tax3 S features are very similar to that of Tax1 and less similar to that of Tax2. In particular, Tax3 S , as Tax1, possesses a PDZbinding domain that has been demonstrated to be involved in the ability of the viral protein to transform rat fibroblasts (Rousset et al., 1998) . Interestingly, this PDZ domain is absent from Tax2, and infection by HTLV-2 does not lead to lymphoproliferative diseases (Endo et al., 2002) . Another critical step in the Tax1-induced transformation process is the persistent activation of the NF-kB pathway and the repression of the p53 tumor suppressor transcriptional activity. We and others have demonstrated that, in T cells, the activation of the NF-kB pathway is a prerequisite for the repression of the p53 (Meertens et al., 2004b; PiseMasison and Brady, 2005) . On the other hand, in Hela or HEK cells, p53 repression is concomitant with the sequestration of CBP and/or p300 co-activators (PiseMasison et al., 2000; Meertens et al., 2004b) .
We have established here that Tax3 S protein possesses both the ability to activate the NF-kB pathway and to bind CBP, and our preliminary results suggest that Tax3 inhibits p53 functions (data not shown). Of note, we have observed that, while the interaction of Tax1 and Tax3 with CBP was equivalent, Tax3 binding to p300 seemed weaker than that of Tax1. Tax1 has been shown to bind at least three separate domains of CBP, which include the KIX domain, the C/H1 domain and the CR2 domain (Harrod et al., 1998; Lemasson and Nyborg, 2001; Scoggin et al., 2001) . To our knowledge, with the exception of the CR2 domain, these important experiments have only been conducted with CBP protein fragments. The binding of Tax1 to the p300 KIX and C/ H1 domains has, therefore, not been specifically investigated. Tax1 and Tax3 bind most strongly to a CBP fusion protein containing the KIX domain alone. Surprisingly, the binding of both Tax1 and Tax3 to CBP is decreased when both the KIX and C/H1 domains are present. Interestingly, Tax1 but not Tax3 interacts with the C/H1 domain of p300. Our results suggest that although similar in function, the interaction of Tax1 and Tax3 with these co-activators may not be identical. Whether these differences between Tax1 and Tax3 impact the putative transforming ability of the proteins remains to be determined.
In addition to Tax, HTLV-1 and HTLV-2 genomes also encode the p30 and p28 proteins, respectively (Nicot et al., 2004; Younis et al., 2004) . Each of these two proteins has been shown to retain the doubly spliced mRNA encoding the Tax and Rex proteins in the nucleus. Therefore, p30 and p28 inhibit virus expression by reducing Tax and Rex protein expression. Given the fact that the ORF corresponding to these proteins is absent from STLV-3 genomes, we are currently determining whether it is also absent from HTLV-3. The lack of p30/p28 might lead to an increased viral expression in vivo with an outcome that remains to be determined.
In conclusion, our data strongly suggest that, at least in vitro, Tax3 has the ability to transform the cells where it is expressed, and imply the eventuality of lymphoproliferative disorders among HTLV-3-infected people.
Materials and methods

Cell culture
HeLa and 293T cell lines were grown in Dulbecco's modified Eagle's medium supplemented with fetal bovine serum (10%) and antibiotics (penicillin 100 U/ml, streptomycin 100 mg/ml). CEM and Jurkat cells were grown in RPMI 1640 supplemented with 10% fetal bovine serum, antibiotics and L-glutamine. All cell lines were maintained at 371C in 5% CO 2 .
GFP-Tax3, Tax-histidine and pSG5M-Tax plasmids Because human HTLV-3 viral RNA is not available, 0.5 mg of total RNA extracted (Rneasy Mini Kit, QIAGEN, Courtaboeuf, France) from a short-term culture of STLV-3 CTO 602 simian cells (Meertens et al., 2002) was used as a matrix for RT-PCR (OneStep RT-PCR kit, QIAGEN). The tax3 cDNA sequence (1050 bp) was amplified using 602TaxEco: 5 0 -ATG GCCCATTTCCCAGGTTTCGG-3 0 and 602TaxBamH1: 5 0 -TCAGACGGATGATTCAGCTATTTGTCC-3 0 primers, and inserted downstream the GFP sequence into the MCS of a pGFP-C3 vector (Clontech, Le pont de Claix, France). The Tax3 cDNA was also cloned into a pET-30a vector and Taxhistidine protein was purified from E. coli by nickel-affinity chromatography (QIAGEN) as described . A similar protocol was used to purify Tax1 and Tax2. Finally, tax3 cDNA was cloned into a pSG5M vector. The nucleotide sequence of the constructs was determined using the DYEnamic ET Terminator Cycle Sequencing Kit (Amersham Biosciences, Piscataway, NJ, USA) on an Applied Biosystems 373A DNA sequencer as previously described (Meertens et al., 2004a) . The pSG5M-Tax3 M22 mutant was constructed by replacing the M 131 amino-acid residue by S 131 using the Quickchange site-directed mutagenesis (Stratagene, La Jolla, CA, USA).
Western immunoblot analyses
At 24 h after transfection, cells were washed twice with PBS and lysed (Tris-HCl pH 7.4 50 mM, NaCl 120 mM, EDTA 5 mM, NP-40 0.5%, Na 3 VO 4 0.2 mM, DTT 1 mM, PMSF 1 mM) in the presence of protease inhibitors (Complete, Boehringer, Meylan, France) and incubated on ice. Cell debris were pelleted by centrifugation. Protein concentration was determined by Bradford (Biorad, Hercules, CA, USA). Samples were loaded into 10% Tris/Glycine gels (Invitrogen, Cergy Pontoise, France), subjected to electrophoresis and transferred onto a polyvinylidene fluoride (PVDF) membrane (Immobilon-P, Millipore, Saint-quentin en yvelines, France). Membranes were blocked in a 5% PBS-milk solution, incubated with anti-flagM2 (Sigma, Lyon, France, M3265, 1:2000) anti-histidine (QIAGEN 34660, 1:2000) or anti-GFP (Clontech 8371, 1:1000) antibodies. The next day, the membranes were washed and incubated either with anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antibodies (Amersham Biosciences) and developed using the SuperSignal West Pico Chemiluminescent substrate Kit (Pierce, Brebie`res, France). To control for the amount of protein loaded per well, membranes were stripped with the Re-blot Plus Kit (Chemicon International, Temecula, CA, USA), and reprobed with a specific anti-b-tubulin antibody (sc9104 Santa Cruz Biotechnology 1:1000). To determine whether the sera from the HTLV-3-infected individual or from the STLV-3-infected monkeys contain specific Tax3 antibodies, 3 mg of purified Tax3-his were loaded on 6% Tris-Glycine gel (Invitrogen) and subsequently probed with serial dilutions (1:250-1:4000) of the serum obtained either from the HTLV-3-infected individual (Calattini et al., 2005) , or with the serum of an uninfected individual. Sera obtained from nine different monkeys, infected or not with STLV-3 (Meertens et al., 2002; , were tested at a 1:250 dilution. The next day, the membrane was washed and incubated with anti-human horseradish peroxidase-conjugated secondary antibodies (1:30 000) (P.A.R.I.S, Compie`gne, France) and developed using the SuperSignal West Pico Chemiluminescent substrate Kit (Pierce). The membranes were then reprobed with an anti-histidine antibody (QIAGEN 34660).
Green fluorescent protein analyses
For microscopic analyses, HeLa cells were seeded on an eightwell chamber glass slide at a concentration of 3.5 Â 10 4 cells/ well and transfected the next day with 0.3 mg of the different GFP plasmids using Effectene reagent (QIAGEN) as described (Meertens et al., 2004a) . At 24 h after transfection, the cells were washed with PBS, fixed with 4% paraformaldehyde (Sigma) and washed with PBS. Nucleic acids were stained with 4 0 -6 0 -diamine-2 phenylindole dihydrochloride (DAPI)-containing mounting medium (Vectashield, Vector, Burlingame, CA, USA). Cells were visualized with a Zeiss Axioplan 2 imaging microscope Â 40 using a Zeiss Axiocam HRc (color) camera and the Zeiss Apotome software.
Luciferase assays CEM cells (10 Â 10 6 ) were electroporated using a Biorad apparatus (250 V, 950 mF) in 0.4 cm cuvettes with HTLV-1-LTR-luc, HTLV-2-LTR-luc, NF-kB-luc plasmids together with pSG5M-Tax plasmids as previously described (Meertens et al., 2004a) . Transient transfection experiments were also performed with Jurkat and 293T cells using the Superfect and the Polyfect procedures, respectively (QIAGEN), as previously described (Meertens et al., 2004b) . The amount of DNA transfected was always equalized by addition of a control pSG5M empty vector. All the transfections were carried out in the presence of a phRG-TK vector in order to normalize the results for the transfection efficiencies. Reporter activities were assayed 24 h post-transfection using the Dual-Luciferase reporter assay system (Promega, Charbonnieres, France) with a Berthold LB9500C luminometer as described (Meertens et al., 2004a) . Because the complete HTLV-3 LTR sequence is yet not available, a 445 bp region encompassing the U3 (i.e. with the TREs) and part of the R sequence (Casoli et al., 2004) was amplified from the proviral STLV-3 DNA extracted from CTO 602 PBMCs using a hemi-nested PCR with the STLV-3 LTR: 5 0 -TGTCAGTGATGATGAGCTTCG-3 0 and STLV-3 LTRASext: 5 0 -GAGAGCTCCAGGGGAGCGG-3 0 primers. The first PCR was followed by a second PCR using STLV-3 LTR and STLV-3LTRint: 5 0 -GGAGTGATGGCCTAGCTC-GAC-3 0 and the fragment was cloned into pGL2-basic after MluI and XhoI digestion.
RT-PCR analyses
At 24 h after transfection of CEM cells, total RNA was extracted with the Rneasy Mini Kit (QIAGEN). The samples were treated with DNAse1 to avoid any carry-over of the Taxcontaining plasmid. Then, 0.5 mg of total RNA was used as a matrix for RT-PCR according to the instructions with the OneStep RT-PCR kit (QIAGEN). PCR was performed using the following Tax primers: STLV-3Taxs 5 0 -CCCGCACMCT CAAGGTYCTCACCCC-3 0 and STLV-3Taxas 5 0 -GGGTCR GGGAARGACATGGCKGGC-3 0 primers, which allow the amplification of a 157 bp PCR product, which was then resolved on a 2.5% agarose gel.
In vitro transcription assay
The cassette DNA template used in the in vitro transcription assays was the 4TxRE (Kashanchi et al., 1998) . Briefly, 4TxRE contains four copies of 21-bp repeat inserted upstream of the HTLV-1 TATA and promoter (À52 to þ 1) and G-free cassette (Figure 5a ). Reactions contained HeLa nuclear extract, 0.5 mg of supercoiled DNA and 50, 100, 200 and 500 ng of the different Tax proteins. Reactions were preincubated for 30 min at 301C. [ 32 P]UTP (10 mCi) was added and incubation continued for 50 min at 301C. [ 32 P]RNA was purified and analysed on a 6% denaturing acrylamide urea gel. Gels were placed on a PhosphorImager cassette for an overnight exposure. Signals were visualized using ImageQuant program (Molecular Dynamics, Bondoufle, France).
Immunoprecipitation CBP and p300 293T cells were transfected using Fugene 6 reagent as previously described (Meertens et al., 2004b) with 0.5 mg of pGFP, pGFP-Tax1, pGFP-Tax2 or pGFP-Tax3 S . At 24 h after transfection, cells were washed twice with cold PBS and lysed in the presence of protease inhibitors for 20 min on ice as previously described (Meertens et al., 2004b) . Whole-cell extracts (200 mg) were incubated with 100 ng of columnpurified his-tagged p300 or his-tagged CBP overnight at 41C as previously described (Lu et al., 2002) . Nickel beads (QIAGEN) were then added and reactions incubated for an additional hour at 41C. After extensive washing with lysis buffer, the complexes were run on 4-20% Tris-Glycine gels (Invitrogen) and electroblotted to PVDF membrane (Immobilon-P). Western blot analysis was performed to detect either GFP-fusion proteins using anti-GFP antibody or histidine-fusion using anti-histidine antibody.
PDZ binding 293T cells were transfected using the Polyfect (QIAGEN) reagent with 4 mg of pGFP, pGFP-Tax1, pGFPTax2 or pGFP-Tax3 S and pSGF-cl.15, a PDZ domaincontaining protein (Rousset et al., 1998) . After 24 h, cells were washed twice with cold PBS and lysed in CHRIS buffer (50 mM Tris-HCl, 0.5 % NP-40, 200 mM NaCl, 0.1 mM EDTA, 10% glycerol) in the presence of protease inhibitors for 30 min. Cell extracts (350 mg) were pre-cleared with IgG anti-mouse Dynabeads M280 beads (Dynal) for 1 h. In all, 15 ml of beads was mixed with anti-flag monoclonal antibody (Sigma) and incubated for 1 h. Beads-anti-flag antibody complex was then added to the pre-cleared cell extracts and incubated for 1 h. After three washing with CHRIS buffer (same as above except 300 mM NaCl), the complexes were run on 10% Tris-Glycine gels (Invitrogen) and electroblotted to PVDF membrane (Immobilon-P). Western blot analysis was performed to detect GFP-fusion proteins using anti-GFP antibody (BD).
In vitro binding of purified Tax1 and Tax3 to CBP and p300 In total, 1 mg of either GST or various other GST-CBP or GST-p300 were bound to tagged Tax1 and Tax3 proteins overnight. All GST proteins were expressed in E. coli, purified and used for in vitro binding (1 mg). Tax1 and Tax3 (500 ng each) were used in a TNE 50 þ 0.1% NP-40 þ 1 mM DTT (500 ml total reaction) buffer for in vitro binding overnight at 41C. Next day, 100 ml of Glutathion beads (30% slurry) were added to each tube and further incubated for 2 h at 41C. Samples were then centrifuged and washed with TNE 1000 þ 1% NP-40 þ 1 mm DTT (NaCl at 1000 mM, and DTT was used for proper Tax folding). Samples were washed two more times with TNE 300 þ 0.1% NP-40 þ 1 mM DTT and TNE 50 þ 0.1% NP-40 þ 1 mM DTT, respectively. Finally, bound proteins were ran on a 4-20% SDS-PAGE. His-taggedTax proteins were detected with a mouse secondary antibody using SuperSignal West Dura (Pierce, Brebie`res, France). The various GST-CBP and GST-p300 constructs have previously been described (Kashanchi et al., 1998; Deng et al., 2000) . Briefly, GST-CBP 1-770 encompasses the KIX and the CH/1 domains, GST-CBP 451-682 corresponds to the KIX domain. GST-p300 1-595 contains the CH/1 domain and p300 construct encompasses part of the HAT domain. Input lane represents 1:5 of Tax starting material for the binding.
